Global News
- All
- AI
- Markets
- Macroeconomics
Netflix shares have been on a roller-coaster ride the past year.
SpaceX isn't the only space company worth watching. It's just the most expensive.
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Insurance companies serve as the backbone of risk management, providing essential protection and financial security for individuals and businesses. But concerns about claims severity and tightening regulations have tempered enthusiasm, limiting the indust
IMAX, a leader in cinematic technology and global theater systems, reported a notable insider sale amid strong one-year share performance.
This start-up wants to become the Nvidia of quantum computing.
Goldman Sachs and Morgan Stanley crunched the numbers on the OBBBA refund bonanza—and the math is brutal. Gas prices wiped it out.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of the
This Menlo Park biotech, focused on monoclonal antibody therapies, reported a notable insider sale amid a year of dramatic share gains.
Tractor Supply stock may shift into higher gear later in the year -- but it still costs too much.
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of
This medical device innovator specializing in breast implants reported a notable insider sale amid strong one-year stock gains.
There are two ways Rivian can generate 1,000% returns.
A year after shocking the market by missing on earnings, UnitedHealth Group manages to delight.